Files
gh-k-dense-ai-claude-scient…/skills/clinical-reports/assets/radiology_report_template.md
2025-11-30 08:30:18 +08:00

7.8 KiB

Radiology Report Template

Patient Information

Patient Name: [Last, First]
Medical Record Number: [MRN]
Date of Birth: [MM/DD/YYYY]
Age: [years]
Sex: [M/F]
Exam Date: [MM/DD/YYYY]
Exam Time: [HH:MM]
Accession Number: [Number]

Referring Physician: [Name]
Ordering Service: [Service/Department]


Examination

Exam Type: [CT/MRI/X-Ray/Ultrasound/PET/Nuclear Medicine scan]
Body Part: [Anatomical region - e.g., Chest, Abdomen and Pelvis, Brain]
Contrast: [Yes - IV/Oral/Both | No]
Laterality: [Right/Left/Bilateral if applicable]


Clinical Indication

[Reason for examination, relevant clinical history, specific question to be answered]

Example: "Rule out pulmonary embolism in patient with acute dyspnea and chest pain. History of recent surgery."


Comparison

Prior Studies:
[Modality] of [body part] from [date]: [Available/Not available for comparison]

Example: "CT chest without contrast from 6 months prior (01/15/2023) available for comparison"

OR: "No prior imaging available for comparison"


Technique

[Detailed description of imaging parameters and protocol]

For CT:

Multidetector CT of the [body region] was performed [without/with] intravenous 
contrast. [Volume] mL of [iodinated contrast agent name] was administered 
intravenously. Images were acquired in the [arterial/venous/delayed] phase(s).
Multiplanar reconstructions were performed.

Technical quality: [Adequate / Limited by motion artifact / Limited by patient body habitus]
Radiation dose (DLP): [mGy-cm]

For MRI:

MRI of the [body region] was performed [without/with] intravenous contrast
using the following sequences: [list sequences - T1, T2, FLAIR, DWI, etc.]
[Volume] mL of [gadolinium-based contrast agent] was administered intravenously.
Multiplanar imaging was obtained.

Technical quality: [Adequate / Limited by motion artifact]

For X-Ray:

[Number] views of the [body part] were obtained: [AP/PA/Lateral/Oblique]
Technical quality: [Adequate penetration and positioning / Limited by...]

For Ultrasound:

Real-time ultrasound examination of the [body part] was performed using 
[linear/curved] array transducer.
Technical quality: [Adequate / Limited by bowel gas / Limited by body habitus]

Findings

[Systematic, comprehensive description of findings organized by anatomical region or organ system]

[Region/Organ 1]

[Detailed findings - size, density/intensity, enhancement pattern, abnormalities]

Normal statement: "[Organ] is normal in size, contour, and [attenuation/signal intensity]. No focal lesions."

Abnormal statement: "[Description of abnormality with measurements]"

Example:

Lungs:
- Bilateral ground-glass opacities are present, predominant in the lower lobes.
- Right lower lobe consolidation measuring 4.5 x 3.2 cm with air bronchograms.
- No pleural effusion or pneumothorax.
- Airways are patent bilaterally.

[Region/Organ 2]

[Findings]

[Additional Regions as Applicable]

For Chest CT:

  • Lungs
  • Airways
  • Pleura
  • Mediastinum and Hila
  • Heart and Great Vessels
  • Chest Wall
  • Upper Abdomen (if included)
  • Bones

For Abdomen/Pelvis CT:

  • Liver
  • Gallbladder
  • Spleen
  • Pancreas
  • Kidneys and Adrenals
  • Gastrointestinal Tract
  • Peritoneum and Mesentery
  • Retroperitoneum
  • Bladder
  • Pelvic Organs
  • Vasculature
  • Lymph Nodes
  • Bones
  • Soft Tissues

For Brain MRI:

  • Brain Parenchyma
  • Ventricles and Cisterns
  • Extra-axial Spaces
  • Vascular Structures
  • Orbits (if included)
  • Skull Base and Calvarium

Measurements (if applicable)

Structure Measurement Normal Range
[Lesion/mass] [Size in cm, 3 dimensions] -
[Organ] [Size] [Normal size]

Impression

[Concise summary of key findings with clinical interpretation]

Format as numbered list in order of clinical importance:

  1. [Most important finding] - [Diagnosis or differential, clinical significance]

    • [Additional details, comparison to prior if applicable]
    • [Recommendation if any]
  2. [Second finding] - [Interpretation]

  3. [Additional findings]

Alternative format for normal study:

No acute intrathoracic abnormality.
Specifically, no evidence of pulmonary embolism.

Recommendations (if applicable):

  • [Further imaging, follow-up imaging interval, clinical correlation, biopsy, etc.]
  • [Timeframe for follow-up]

Example:

Recommend follow-up CT in 3 months to assess for interval change.
Clinical correlation with laboratory values recommended.
Consider PET/CT for further characterization if clinically indicated.

Communication of Critical Results

[If critical/urgent finding]

Critical finding: [Description]

Communicated to: [Name and role of person notified]
Date/Time: [MM/DD/YYYY at HH:MM]
Method: [Phone call / Page / In person]
Read back verified: [Yes]


Structured Reporting (if applicable)

For Lung Nodules (Lung-RADS):

Category: [Lung-RADS 0/1/2/3/4A/4B/4X]
Recommendation: [Per Lung-RADS guidelines]

For Breast Imaging (BI-RADS):

Category: [BI-RADS 0/1/2/3/4/5/6]
Recommendation: [Per BI-RADS guidelines]

For Liver Lesions (LI-RADS):

Category: [LI-RADS 1/2/3/4/5/M/TIV]
Features: [Arterial phase hyperenhancement, washout, capsule, size, growth]

For Prostate (PI-RADS):

Score: [PI-RADS 1/2/3/4/5]
Location: [Peripheral zone / Transition zone]


Signature

Interpreted by:
[Radiologist name, MD]
[Board certification]
[NPI number if required]

Electronically signed: [Date and time]

Dictated: [Date and time]
Transcribed: [Date and time]
Signed: [Date and time]


Template Notes

General Principles

Be systematic:

  • Use consistent order (head to toe, outside to inside)
  • Don't skip regions even if normal
  • Include pertinent negatives

Be specific:

  • Provide measurements (size in 3 dimensions for masses)
  • Describe location precisely
  • Use standardized terminology (RadLex)
  • Quantify when possible

Be clear:

  • Avoid ambiguous language
  • Make impression stand-alone
  • Answer the clinical question directly
  • State what IS present, not just what isn't

Communication:

  • Critical findings require immediate verbal notification
  • Document communication
  • Provide specific recommendations
  • Suggest next steps when appropriate

Measurement Guidelines

Lesions/Masses:

  • Three dimensions: [length x width x height in cm]
  • Use consistent measurement method for follow-up

Lymph Nodes:

  • Short axis diameter in cm
  • Note morphology (round vs. oval)

Organ Sizes:

  • Use established normal ranges
  • Age and sex appropriate

Comparison Statements

Improved: "Interval decrease in size of right upper lobe mass from 3.5 cm to 2.1 cm."

Stable: "Unchanged 8 mm left lower lobe nodule, stable for 2 years."

Worsened: "Interval increase in bilateral pleural effusions, now moderate on the right."

New finding: "New 1.5 cm right adrenal nodule, not present on prior CT."

Differential Diagnosis Language

Definite: "Consistent with..."
Probable: "Most likely represents..." or "Favors..."
Possible: "Suggestive of..." or "Differential diagnosis includes..."
Uncertain: "Cannot exclude..." or "Consider..."

Recommendations

Follow-up imaging:

  • Specify modality, timing, and what to assess
  • "Recommend CT chest in 6-12 months to assess stability"

Further characterization:

  • "Consider MRI for further characterization"
  • "Ultrasound correlation recommended"

Clinical correlation:

  • "Clinical correlation with tumor markers recommended"
  • "Correlate with patient symptoms and physical examination"

Biopsy/Intervention:

  • "Consider biopsy for definitive diagnosis"
  • "Amenable to image-guided biopsy if clinically indicated"